about
Low-Magnitude Mechanical Stimulation to Improve Bone Density in Persons of Advanced Age: A Randomized, Placebo-Controlled Trial.Impact of Hepatitis C Virus Infection on Children and Their Caregivers: Quality of Life, Cognitive, and Emotional OutcomesWarfarin versus aspirin in patients with reduced cardiac ejection fraction (WARCEF): rationale, objectives, and designSilent Cerebral Infarct Transfusion (SIT) trial imaging core: application of novel imaging information technology for rapid and central review of MRI of the brain.Long-term safety and efficacy of a cholesterol-lowering diet in children with elevated low-density lipoprotein cholesterol: seven-year results of the Dietary Intervention Study in Children (DISC).Morphine, hypotension, and adverse outcomes among preterm neonates: who's to blame? Secondary results from the NEOPAIN trial.Climatic and geographic temporal patterns of pain in the Multicenter Study of Hydroxyurea.Individual and composite study endpoints: separating the wheat from the chaff.Angiographic and clinical outcomes of drug-eluting versus bare metal stent deployment in the Occluded Artery Trial.Adherence to hip protectors and implications for U.S. long-term care settings.Evaluating progression of liver disease from repeat liver biopsies in children with chronic hepatitis C: a retrospective study.Adolescent diet and subsequent serum hormones, breast density, and bone mineral density in young women: results of the Dietary Intervention Study in Children follow-up study.Self-reported adherence with the use of a device in a clinical trial as validated by electronic monitors: the VIBES studyThe impact of prior authorization on buprenorphine dose, relapse rates, and cost for Massachusetts Medicaid beneficiaries with opioid dependence.The combination of ribavirin and peginterferon is superior to peginterferon and placebo for children and adolescents with chronic hepatitis C.Prevalence and risk factors for postpartum depression symptoms among women with disabilities.Peginterferon with or without ribavirin has minimal effect on quality of life, behavioral/emotional, and cognitive outcomes in childrenHydroxyurea and sickle cell anemia: effect on quality of life.Insights from the conduct of a device trial in older persons: low magnitude mechanical stimulation for musculoskeletal health.Viral infection of engrafted human islets leads to diabetes.Understanding multifactorial influences on the continuum of maternal weight trajectories in pregnancy and early postpartum: study protocol, and participant baseline characteristics.Clinical findings, diagnostics and outcome in 33 cats with adrenal neoplasia (2002-2013).Adolescent diet and metabolic syndrome in young women: results of the Dietary Intervention Study in Children (DISC) follow-up study.Cognitive testing for dementia is adversely affected by administration in a foreign location.Co-occurring risk factors for arrest among persons with opioid abuse and dependence: implications for developing interventions to limit criminal justice involvement.A Randomized, Double-Blind, Placebo-Controlled Trial of Adjunctive Metformin Therapy in Overweight/Obese Youth with Type 1 Diabetes.Childhood overweight and cardiovascular disease risk factors: the National Heart, Lung, and Blood Institute Growth and Health StudyRisk Factors for Relapse and Higher Costs Among Medicaid Members with Opioid Dependence or Abuse: Opioid Agonists, Comorbidities, and Treatment HistoryPegylated interferon for chronic hepatitis C in children affects growth and body composition: results from the pediatric study of hepatitis C (PEDS-C) trial.Recruitment and retention strategies in a clinical trial for children with chronic hepatitis C infectionHow many therapists? Practical guidance on investigating therapist effects in randomized controlled trials for eating disordersAutoantibodies and autoimmune disease during treatment of children with chronic hepatitis C.Designing interventions to overcome poor numeracy and improve medication adherence in chronic illness, including HIV/AIDS.Height, adiposity and body fat distribution and breast density in young women.The Hip Impact Protection Project: design and methods.Predictors of outcome and the lack of effect of percutaneous coronary intervention across the risk strata in patients with persistent total occlusion after myocardial infarction: Results from the OAT (Occluded Artery Trial) study.Design of the PEDS-C trial: pegylated interferon +/- ribavirin for children with chronic hepatitis C viral infection.Family cohesion moderates the relation between free testosterone and delinquent behaviors in adolescent boys and girls.Comparison between two labeled agents in mice using a coinjection-ratio approach in contrast to a conventional group approach.A gender analysis of the study of pharmacotherapy of psychotic depression (STOP-PD): gender and age as predictors of response and treatment-associated changes in body mass index and metabolic measures
P50
Q27334422-16C3CE41-6B5F-4D5B-A473-07283D373B41Q27487975-D176B55A-87A9-4D29-A9FB-4CD088E4791FQ28195377-DC6AA37D-FB5F-48C6-8C1B-B06B2206361EQ31152018-A968ACC0-378E-42A2-BE57-4B8E277E4A73Q31832750-847BD608-692F-49E8-9791-7FC68DAA5719Q33366080-6ABD7661-3457-4945-8E6F-8CBA2D23578AQ33443329-EF2C65D1-E312-4563-B051-AEE5D3D6373DQ33606234-2CA3C146-C4E9-48FE-B302-C63CF0C708DEQ33642414-7A408A45-D9C6-43A5-8906-24C7E4A8CB6DQ33757291-31A04144-46C3-42C2-AB2E-A00F888F1E49Q33862153-36069780-C7BF-4038-BCB4-5252FDD4BA4EQ33903214-DAADF692-DB67-4793-9491-304DE1FE3E5BQ34476474-3FD89734-A7DB-4799-B148-51EEBF09619BQ34543555-FA03340A-6463-4081-A02C-4108DD46F134Q34588247-7B3FC09B-C9E2-46E6-BA8C-0DC02F36E342Q34627239-45D6E0DA-6C91-47A4-9034-43615714E43DQ34861058-B795D32E-A145-477E-A0FE-15C7FA9DB760Q35038868-7BC7F368-7CA3-44AD-9781-8CBC5B416339Q35105497-E10A7304-0B1E-4F94-B84E-CD31E3D39D84Q35220557-DC929501-14AA-49B0-9C73-61EB85A7DE18Q35314889-BDD58A83-F197-4361-BA56-2D64CC48FBF7Q35567431-3C991264-4DBA-4730-BC2E-734B19E80D62Q35597891-A6D2D49B-C950-4A88-B031-6F361D7C141AQ35608596-356850EE-1B42-4895-8A17-6B0AA1F18153Q35647148-26AFD2D1-F1E1-48C8-98D2-97E33157F331Q35772825-DA75B79E-460A-422E-9D05-AF7776C93A47Q35933270-5520B0A8-F4C1-4006-A0C6-061DC8385CB7Q36030834-0415FAF3-CD5A-4E1E-9544-3C6332A4C9B7Q36055220-45FFF47D-69D9-4073-B865-3BE7E17FB2BDQ36518161-D8CF40E7-59B5-4E12-AE82-475EF3DACA4DQ36580207-37588E7D-E65A-4722-AF1D-24C08696B666Q36641415-2AB22B3A-5057-4B53-8542-E42C3E947583Q36888074-CA13B988-2B51-457C-846A-D23AC051E308Q36924450-F8636EB9-7D64-4530-8649-E803D2059A76Q37050734-FC7DED7A-7D2A-4914-9830-BDE318FB38FFQ37082952-5BF7C2B4-B91F-42DE-B0A6-3FB5E53A547BQ37126749-202D0FFB-7D49-4C8A-B662-2ED28347B92EQ37204980-FC378F05-0572-4EE3-A275-19BA5EE9044BQ37373494-22B0C6EA-36DD-4055-86B1-60BA3E63FB53Q37663969-69471177-509E-4835-876F-94E9745BECCB
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Bruce Barton
@ast
Bruce Barton
@en
Bruce Barton
@es
Bruce Barton
@nl
Bruce Barton
@sl
بروس بارتون
@ar
type
label
Bruce Barton
@ast
Bruce Barton
@en
Bruce Barton
@es
Bruce Barton
@nl
Bruce Barton
@sl
بروس بارتون
@ar
prefLabel
Bruce Barton
@ast
Bruce Barton
@en
Bruce Barton
@es
Bruce Barton
@nl
Bruce Barton
@sl
بروس بارتون
@ar
P106
P1153
7102770926
P21
P31
P496
0000-0001-7878-8895